GSK expands efforts to fight antimicrobial resistance in Vietnam

GSK expands efforts to fight antimicrobial resistance in Vietnam

GSK Vietnam steps up action against antimicrobial resistance, promoting rational antibiotic use and wider vaccine coverage.
University of Medicine and Pharmacy develops vaccinology postgrad course

University of Medicine and Pharmacy develops vaccinology postgrad course

The University of Medicine and Pharmacy at Ho Chi Minh City held a seminar on strategic directions for its vaccinology postgraduate curriculum on November 10.
Nearly one in four adolescents carry invasive meningococcal disease without symptoms

Nearly one in four adolescents carry invasive meningococcal disease without symptoms

The Vietnam Association of Preventive Medicine in collaboration with GSK Vietnam have held a symposium on invasive meningococcal disease.
Prevention the key to addressing respiratory health challenges

Prevention the key to addressing respiratory health challenges

Amid growing cases of pulmonary-related diseases, prevention is considered the key to addressing respiratory health challenges, according to experts.
GSK leads global forum to address respiratory health challenges

GSK leads global forum to address respiratory health challenges

GSK hosted the third annual RespiVerse meeting on December 13-14 in Bangkok, Thailand, bringing together renowned international speakers and healthcare professionals from 17 countries to address pressing challenges in respiratory diseases.
Adult vaccination and shingles prevention in Vietnam

Adult vaccination and shingles prevention in Vietnam

The Vietnam Medical Association, in collaboration GSK Vietnam, held a roundtable in Hanoi to discuss adult immunisation and shingle prevention on November 21.
First international summit on shingles prevention held in Vietnam

First international summit on shingles prevention held in Vietnam

GSK organised a series of international scientific summits for healthcare professionals in emerging markets in three countries in October and November, including Colombia, Dubai (UAE) in October, and Vietnam in collaboration with Vietnam Medical Associati
GSK: from treatment to prevention for healthy ageing

GSK: from treatment to prevention for healthy ageing

Dr. Pham Thi My Lien, president of GSK Vietnam, spoke with VIR’s Bich Thuy about the importance of adult vaccinations, one of the most effective interventions contributing to improved quality of life, reducing the burden on healthcare, the economy, and society.
Pharmaceutical players seek expansion of rights in Vietnam

Pharmaceutical players seek expansion of rights in Vietnam

While continuing to make positive business results in Vietnam’s pharma market in the first half of 2024, multinationals are seeking an expansion of their rights.
COPD treatment is of utmost importance

COPD treatment is of utmost importance

Professor Paul Jones, emeritus professor of Respiratory Medicine at St George’s University of London, shared his perspectives on COPD.
GSK Vietnam and EPLUS partner to increase access to new vaccines

GSK Vietnam and EPLUS partner to increase access to new vaccines

GSK Vietnam and EPLUS Research JSC have signed an MoU to bring the latest innovations in medicines and vaccines to Vietnam.
The UK continues celebrating successes in healthcare sector in Vietnam

The UK continues celebrating successes in healthcare sector in Vietnam

The UK Prime Minister’s Trade Envoy to Vietnam, Mark Garnier, on March 15 visited GSK's warehouse in Ho Chi Minh City during his first official visit to the Southeast Asian nation.
Pharma giants gaining big in 2022

Pharma giants gaining big in 2022

International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine

Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine

Sanofi and GSK on February 23 announced that they intend to submit data from both their booster and phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccines.
Post COVID-19: Burden doubles as childhood immunisations are disrupted

Post COVID-19: Burden doubles as childhood immunisations are disrupted

Due to COVID-19, tens of millions of children have missed out on life-saving vaccines, threatening the risk of outbreaks of diseases.
1 2